MarketInOut Stock Screener Log In | Sign Up

Dare Bioscience Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/30/2026
Dare Bioscience Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization13.76 mln
Float17.36 mln
Earnings Date11/05/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

29.61
Highly suspicious

1-Year Forecast

6.75
Transformational upside

Relative Strength

29 / 100
Underperforming

Pre-Tax Margin

-804%
Severely loss-making

ROE

-748
Deeply negative

Business Description

Daré Bioscience Inc. is a San Diego-based company founded in 2015 that focuses on developing medical treatments for women's health, including contraception, fertility, menopause, pelvic pain, and vaginal and sexual health. Its marketed product, XACIATO, is an antibacterial gel used to treat bacterial vaginosis, while its broad pipeline includes hormone-free contraceptives, pain relief treatments, menopause therapies, and solutions for HPV-related conditions. The company also pursues innovations in preterm birth prevention, fertility support, and non-hormonal contraception for both men and women.

Key Fundamentals

EPS-0.71
ROE-748
RPS0.10
ROIC-47.00
ROA-43.46
Interest Cover-55.72
EBITDA, mln-7.64
EV / EBITDA-0.86
EV / EBIT-0.65
Revenue, mln1.37
EV / Revenue4.83

Quote Details

Last 0.6996
Change 0.0181 (2.66%)
Open 0.7026
Volume 650,383
Turnover 455,008
Average Volume 137,654

Financial Ratios

Pre-Tax Profit Margin-804
Current Ratio0.99
Price / Sales7.03

Financial Strength

Altman Z-Score-13.3
Piotroski F-Score 5 / 9
Beneish M-Score29.61
1-Year Target Price6.75
Short Ratio5.59
Short % of Float5.84

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.31% 92 / 100   
1 Month -17.79% 20 / 100   
2 Months -47% 9 / 100   
6 Months -70.1% 7 / 100   
1 Year -65.37% 13 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog